Exact Mass: 548.2522

Archangelolide

C29H40O10 (548.2621)

Tamoxifen-N-glucuronide

C32H38NO7 (548.2648)

Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

Murabutide

C23H40N4O11 (548.2693)

Trh-gly-lys

C24H36N8O7 (548.2707)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Murabutida

C23H40N4O11 (548.2693)

PA(2:0/PGE2)

C25H41O11P (548.2386)

PA(2:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/2:0)

C25H41O11P (548.2386)

PA(PGE2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/2:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGD2)

C25H41O11P (548.2386)

PA(2:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/2:0)

C25H41O11P (548.2386)

PA(PGD2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/2:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H41O11P (548.2386)

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0)

C25H41O11P (548.2386)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Baccharol

C29H40O10 (548.2621)

Baccharisol

C29H40O10 (548.2621)

Baccharinoid B 20

C29H40O10 (548.2621)

Scuteselerin

C29H40O10 (548.2621)

[7R(R)]-2-Deoxy-7-deoxo-4,16-dihydroxy-7-(1-hydroxyethyl)verrucarin A

C29H40O10 (548.2621)

8-Acetylarteminolide

C32H36O8 (548.241)

15beta-Hydroxycalotropin

C29H40O10 (548.2621)

Shizukaol J

C32H36O8 (548.241)

19-Epi-(+)-echitoveniline

C31H36N2O7 (548.2522)

Scutalpin E

C29H40O10 (548.2621)

Areptin B

C29H40O10 (548.2621)

A diterpenoid isolated from the aerial parts of Ajuga reptans.

Clerodendrin G

C29H40O10 (548.2621)

[7R(R)]-7-Deoxo-16-hydroxy-7-(1-hydroxyethyl)verrucarin A

C29H40O10 (548.2621)

Asukamycin A-II

C31H36N2O7 (548.2522)

Cycloshizukaol A

C32H36O8 (548.241)

A natural product found in Chloranthus japonicus.

Baccharin B2

C29H40O10 (548.2621)

Baccharin B 3

C29H40O10 (548.2621)

15beta-Hydroxycalactin

C29H40O10 (548.2621)

6R,7E,9R-megastigma-4,7-dien-3-one 9,13-di-O-beta-D-glucopyranoside

C25H40O13 (548.2469)

Neuro_000137

C29H40O10 (548.2621)

[2R,7R(S),8R]-7-Deoxo-8-hydroxy-7-(1-hydroxyethyl)verrucarin A

C29H40O10 (548.2621)

Scutalpin D

C29H40O10 (548.2621)

ajugamarin|Ajugamarin A1|Ajugamarin AI

C29H40O10 (548.2621)

artanomaloide

C32H36O8 (548.241)

16alpha-hydroxycalotropin

C29H40O10 (548.2621)

4,8-dihydroxy-3-methoxy-11-oxo-1,6-dipentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid benzyl ester

C32H36O8 (548.241)

(Ra)-3-phenylacrylic acid 7-hydroxy-2,3,10,11,12-pentamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c]cycloocten-1-yl ester|neglschisandrin C

C32H36O8 (548.241)

C29H40O10

C29H40O10 (548.2621)

8,9,10,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2H-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.03,12.05,10.015,23.018,22]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

12beta-hydroxycalotropin

C29H40O10 (548.2621)

Affinoside Le

C29H40O10 (548.2621)

isopatagonic acid

C32H36O8 (548.241)

Casearin P

C29H40O10 (548.2621)

19-hydroxyingol 12,19-diacetate 8-tiglate

C29H40O10 (548.2621)

ajugareptansone A

C29H40O10 (548.2621)

3-O-(2,6-Dideoxy-beta-D-xylo-hexopyranoside)-3,5,11,14-Tetrahydroxy-19-oxocarda-6,20(22)-dienolide

C29H40O10 (548.2621)

calactinic acid

C29H40O10 (548.2621)

3-Angeloyl,8-(2-methylbutanoyl),14,15-di-Ac-(3beta,8beta,9beta)-14,15-Epoxy-4-isocedrene-3,8,9,14,15-pentol

C29H40O10 (548.2621)

C25H40O13

C25H40O13 (548.2469)

14,15-Dihydrojodrellin T

C29H40O10 (548.2621)

3-(hexopyranosyloxy)-14-hydroxy-19-oxocarda-5,20(22)-dienolide

C29H40O10 (548.2621)

(3S,5S)-1,7-bis(3,4,5-trimethoxyphenyl)heptane-3,5-diyl diacetate|(3S,5S)-3,5-diacetoxy-1,7-bis(3,4,5-trimethoxyphenyl)heptane

C29H40O10 (548.2621)

(4beta,5beta,6alpha,18R,22R)-6-chloro-18,20-epoxy-18-ethoxy-4,5,22-trihydroxy-1-oxoergost-2,24-dien-26-oic acid gamma-lactone|withaphysalin U

C30H41ClO7 (548.2541)

6,9-dihydroxymegastigmasta-5,7-dien-3-one 9-O-beta-D-gentiobioside

C25H40O13 (548.2469)

2-O-beta-D-Glucopyranoside-Andirobicin B

C29H40O10 (548.2621)

JBIR-52

C27H36N2O10 (548.237)

artanomadimer A

C32H36O8 (548.241)

klymollin J

C26H41ClO10 (548.2388)

artanomadimer F

C32H36O8 (548.241)

(20S,22R)-15alpha-acetoxy-5alpha-chloro-6beta,14beta-dihydroxy-1-oxowitha-2,24-dienolide|(5alpha,6beta,14beta,15alpha,22R)-5-chloro-6,14-dihydroxy-1,26-dioxo-22,26-epoxyergosta-2,24-dien-15-yl acetate

C30H41ClO7 (548.2541)

6-hydroxycalactin

C29H40O10 (548.2621)

bistratamide I

C25H36N6O6S (548.2417)

A homodetic cyclic peptide that consists of L-valine and L-threonine as the amino acid residues. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line.

arisanlactone C

C29H40O10 (548.2621)

rel-(3aR,5aS,6S,7aR,7bS,11R,11aR,12aS,13aR)-11-[(2R,3R,5R,8S)-3,8-dimethyl-7-oxo-1,6-dioxaspiro[4.4]non-2-yl]-tetradecahydro-6,12a-dihydroxy-5,5,11-trimethyl-2H,9H-furo[3,2:2,3]furo[3,4:5,6]azuleno[1,2-b]pyran-2,9-dione|schintrilactone C

C29H40O10 (548.2621)

Galericulin

C29H40O10 (548.2621)

16-Hydroxy-Roridin A

C29H40O10 (548.2621)

asterriquinone SU5504

C35H36N2O4 (548.2675)

scutalpin B

C29H40O10 (548.2621)

(22S,23R)-5alpha-chloro-12alpha,22-epoxy-12beta-ethoxy-6beta,17beta-dihydroxy-1-oxowitha-2,24-dien-26,23-olide|12-O-ethyljaborosalactone 42

C30H41ClO7 (548.2541)

18,20-epoxycalotropin

C29H40O10 (548.2621)

Ser Val Gln Glu Ser

C21H36N6O11 (548.2442)

Ser Ser Val Gln Glu

C21H36N6O11 (548.2442)

Met Thr Asn Leu Gly

C22H40N6O8S (548.2628)

C29H40O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-1,3a,11,11a-tetrahydroxy-9,15a-dimethyl-, (1S,3aS,3bR,6aR,9R,11R,11aS,12aR,13aR,15aS)

C29H40O10 (548.2621)

Ala Ser Trp Trp

C28H32N6O6 (548.2383)

Ala Trp Ser Trp

C28H32N6O6 (548.2383)

Ala Trp Trp Ser

C28H32N6O6 (548.2383)

Cys Asp Arg Arg

C19H36N10O7S (548.2489)

Cys Ile Gln Trp

C25H36N6O6S (548.2417)

Cys Ile Trp Gln

C25H36N6O6S (548.2417)

Cys Leu Gln Trp

C25H36N6O6S (548.2417)

Cys Leu Trp Gln

C25H36N6O6S (548.2417)

Cys Gln Ile Trp

C25H36N6O6S (548.2417)

Cys Gln Leu Trp

C25H36N6O6S (548.2417)

Cys Gln Trp Ile

C25H36N6O6S (548.2417)

Cys Gln Trp Leu

C25H36N6O6S (548.2417)

Cys Arg Asp Arg

C19H36N10O7S (548.2489)

Cys Arg Arg Asp

C19H36N10O7S (548.2489)

Cys Trp Ile Gln

C25H36N6O6S (548.2417)

Cys Trp Leu Gln

C25H36N6O6S (548.2417)

Cys Trp Gln Ile

C25H36N6O6S (548.2417)

Cys Trp Gln Leu

C25H36N6O6S (548.2417)

Asp Cys Arg Arg

C19H36N10O7S (548.2489)

Asp Lys Thr Trp

C25H36N6O8 (548.2594)

Asp Lys Trp Thr

C25H36N6O8 (548.2594)

Asp Met Gln Arg

C20H36N8O8S (548.2377)

Asp Met Arg Gln

C20H36N8O8S (548.2377)

Asp Gln Met Arg

C20H36N8O8S (548.2377)

Asp Gln Arg Met

C20H36N8O8S (548.2377)

Asp Arg Cys Arg

C19H36N10O7S (548.2489)

Asp Arg Met Gln

C20H36N8O8S (548.2377)

Asp Arg Gln Met

C20H36N8O8S (548.2377)

Asp Arg Arg Cys

C19H36N10O7S (548.2489)

Asp Thr Lys Trp

C25H36N6O8 (548.2594)

Asp Thr Trp Lys

C25H36N6O8 (548.2594)

Asp Trp Lys Thr

C25H36N6O8 (548.2594)

Asp Trp Thr Lys

C25H36N6O8 (548.2594)

Glu Lys Ser Trp

C25H36N6O8 (548.2594)

Glu Lys Trp Ser

C25H36N6O8 (548.2594)

Glu Met Asn Arg

C20H36N8O8S (548.2377)

Glu Met Arg Asn

C20H36N8O8S (548.2377)

Glu Asn Met Arg

C20H36N8O8S (548.2377)

Glu Asn Arg Met

C20H36N8O8S (548.2377)

Glu Arg Met Asn

C20H36N8O8S (548.2377)

Glu Arg Asn Met

C20H36N8O8S (548.2377)

Glu Ser Lys Trp

C25H36N6O8 (548.2594)

Glu Ser Trp Lys

C25H36N6O8 (548.2594)

Glu Trp Lys Ser

C25H36N6O8 (548.2594)

Glu Trp Ser Lys

C25H36N6O8 (548.2594)

Gly Met Arg Trp

C24H36N8O5S (548.2529)

Gly Met Trp Arg

C24H36N8O5S (548.2529)

Gly Arg Met Trp

C24H36N8O5S (548.2529)

Gly Arg Trp Met

C24H36N8O5S (548.2529)

Gly Thr Trp Trp

C28H32N6O6 (548.2383)

Gly Trp Met Arg

C24H36N8O5S (548.2529)

Gly Trp Arg Met

C24H36N8O5S (548.2529)

Gly Trp Thr Trp

C28H32N6O6 (548.2383)

Gly Trp Trp Thr

C28H32N6O6 (548.2383)

His His Gln Gln

C22H32N10O7 (548.2455)

His Met Val Tyr

C25H36N6O6S (548.2417)

His Met Tyr Val

C25H36N6O6S (548.2417)

His Gln His Gln

C22H32N10O7 (548.2455)

His Gln Gln His

C22H32N10O7 (548.2455)

His Val Met Tyr

C25H36N6O6S (548.2417)

His Val Tyr Met

C25H36N6O6S (548.2417)

His Tyr Met Val

C25H36N6O6S (548.2417)

His Tyr Val Met

C25H36N6O6S (548.2417)

Ile Cys Gln Trp

C25H36N6O6S (548.2417)

Ile Cys Trp Gln

C25H36N6O6S (548.2417)

Ile Gln Cys Trp

C25H36N6O6S (548.2417)

Ile Gln Trp Cys

C25H36N6O6S (548.2417)

Ile Trp Cys Gln

C25H36N6O6S (548.2417)

Ile Trp Gln Cys

C25H36N6O6S (548.2417)

Lys Asp Thr Trp

C25H36N6O8 (548.2594)

Lys Asp Trp Thr

C25H36N6O8 (548.2594)

Lys Glu Ser Trp

C25H36N6O8 (548.2594)

Lys Glu Trp Ser

C25H36N6O8 (548.2594)

Lys Ser Glu Trp

C25H36N6O8 (548.2594)

Lys Ser Trp Glu

C25H36N6O8 (548.2594)

Lys Thr Asp Trp

C25H36N6O8 (548.2594)

Lys Thr Trp Asp

C25H36N6O8 (548.2594)

Lys Trp Asp Thr

C25H36N6O8 (548.2594)

Lys Trp Glu Ser

C25H36N6O8 (548.2594)

Lys Trp Ser Glu

C25H36N6O8 (548.2594)

Lys Trp Thr Asp

C25H36N6O8 (548.2594)

Leu Cys Gln Trp

C25H36N6O6S (548.2417)

Leu Cys Trp Gln

C25H36N6O6S (548.2417)

Leu Gln Cys Trp

C25H36N6O6S (548.2417)

Leu Gln Trp Cys

C25H36N6O6S (548.2417)

Leu Trp Cys Gln

C25H36N6O6S (548.2417)

Leu Trp Gln Cys

C25H36N6O6S (548.2417)

Met Asp Gln Arg

C20H36N8O8S (548.2377)

Met Asp Arg Gln

C20H36N8O8S (548.2377)

Met Glu Asn Arg

C20H36N8O8S (548.2377)

Met Glu Arg Asn

C20H36N8O8S (548.2377)

Met Gly Arg Trp

C24H36N8O5S (548.2529)

Met Gly Trp Arg

C24H36N8O5S (548.2529)

Met His Val Tyr

C25H36N6O6S (548.2417)

Met His Tyr Val

C25H36N6O6S (548.2417)

Met Asn Glu Arg

C20H36N8O8S (548.2377)

Met Asn Arg Glu

C20H36N8O8S (548.2377)

Met Asn Val Trp

C25H36N6O6S (548.2417)

Met Asn Trp Val

C25H36N6O6S (548.2417)

Met Gln Asp Arg

C20H36N8O8S (548.2377)

Met Gln Arg Asp

C20H36N8O8S (548.2377)

Met Arg Asp Gln

C20H36N8O8S (548.2377)

Met Arg Glu Asn

C20H36N8O8S (548.2377)

Met Arg Gly Trp

C24H36N8O5S (548.2529)

Met Arg Asn Glu

C20H36N8O8S (548.2377)

Met Arg Gln Asp

C20H36N8O8S (548.2377)

Met Arg Trp Gly

C24H36N8O5S (548.2529)

Met Val His Tyr

C25H36N6O6S (548.2417)

Met Val Asn Trp

C25H36N6O6S (548.2417)

Met Val Trp Asn

C25H36N6O6S (548.2417)

Met Val Tyr His

C25H36N6O6S (548.2417)

Met Trp Gly Arg

C24H36N8O5S (548.2529)

Met Trp Asn Val

C25H36N6O6S (548.2417)

Met Trp Arg Gly

C24H36N8O5S (548.2529)

Met Trp Val Asn

C25H36N6O6S (548.2417)

Met Tyr His Val

C25H36N6O6S (548.2417)

Met Tyr Val His

C25H36N6O6S (548.2417)

Asn Glu Met Arg

C20H36N8O8S (548.2377)

Asn Glu Arg Met

C20H36N8O8S (548.2377)

Asn Met Glu Arg

C20H36N8O8S (548.2377)

Asn Met Arg Glu

C20H36N8O8S (548.2377)

Asn Met Val Trp

C25H36N6O6S (548.2417)

Asn Met Trp Val

C25H36N6O6S (548.2417)

Asn Pro Arg Tyr

C24H36N8O7 (548.2707)

Asn Pro Tyr Arg

C24H36N8O7 (548.2707)

Asn Arg Glu Met

C20H36N8O8S (548.2377)

Asn Arg Met Glu

C20H36N8O8S (548.2377)

Asn Arg Pro Tyr

C24H36N8O7 (548.2707)

Asn Arg Tyr Pro

C24H36N8O7 (548.2707)

Asn Val Met Trp

C25H36N6O6S (548.2417)

Asn Val Trp Met

C25H36N6O6S (548.2417)

Asn Trp Met Val

C25H36N6O6S (548.2417)

Asn Trp Val Met

C25H36N6O6S (548.2417)

Asn Tyr Pro Arg

C24H36N8O7 (548.2707)

Asn Tyr Arg Pro

C24H36N8O7 (548.2707)

Pro Asn Arg Tyr

C24H36N8O7 (548.2707)

Pro Asn Tyr Arg

C24H36N8O7 (548.2707)

Pro Arg Asn Tyr

C24H36N8O7 (548.2707)

Pro Arg Tyr Asn

C24H36N8O7 (548.2707)

Pro Tyr Asn Arg

C24H36N8O7 (548.2707)

Pro Tyr Arg Asn

C24H36N8O7 (548.2707)

Gln Cys Ile Trp

C25H36N6O6S (548.2417)

Gln Cys Leu Trp

C25H36N6O6S (548.2417)

Gln Cys Trp Ile

C25H36N6O6S (548.2417)

Gln Cys Trp Leu

C25H36N6O6S (548.2417)

Gln Asp Met Arg

C20H36N8O8S (548.2377)

Gln Asp Arg Met

C20H36N8O8S (548.2377)

Gln His His Gln

C22H32N10O7 (548.2455)

Gln His Gln His

C22H32N10O7 (548.2455)

Gln Ile Cys Trp

C25H36N6O6S (548.2417)

Gln Ile Trp Cys

C25H36N6O6S (548.2417)

Gln Leu Cys Trp

C25H36N6O6S (548.2417)

Gln Leu Trp Cys

C25H36N6O6S (548.2417)

Gln Met Asp Arg

C20H36N8O8S (548.2377)

Gln Met Arg Asp

C20H36N8O8S (548.2377)

Gln Gln His His

C22H32N10O7 (548.2455)

Gln Arg Asp Met

C20H36N8O8S (548.2377)

Gln Arg Met Asp

C20H36N8O8S (548.2377)

Gln Trp Cys Ile

C25H36N6O6S (548.2417)

Gln Trp Cys Leu

C25H36N6O6S (548.2417)

Gln Trp Ile Cys

C25H36N6O6S (548.2417)

Gln Trp Leu Cys

C25H36N6O6S (548.2417)

Arg Cys Asp Arg

C19H36N10O7S (548.2489)

Arg Cys Arg Asp

C19H36N10O7S (548.2489)

Arg Asp Cys Arg

C19H36N10O7S (548.2489)

Arg Asp Met Gln

C20H36N8O8S (548.2377)

Arg Asp Gln Met

C20H36N8O8S (548.2377)

Arg Asp Arg Cys

C19H36N10O7S (548.2489)

Arg Glu Met Asn

C20H36N8O8S (548.2377)

Arg Glu Asn Met

C20H36N8O8S (548.2377)

Arg Gly Met Trp

C24H36N8O5S (548.2529)

Arg Gly Trp Met

C24H36N8O5S (548.2529)

Arg Met Asp Gln

C20H36N8O8S (548.2377)

Arg Met Glu Asn

C20H36N8O8S (548.2377)

Arg Met Gly Trp

C24H36N8O5S (548.2529)

Arg Met Asn Glu

C20H36N8O8S (548.2377)

Arg Met Gln Asp

C20H36N8O8S (548.2377)

Arg Met Trp Gly

C24H36N8O5S (548.2529)

Arg Asn Glu Met

C20H36N8O8S (548.2377)

Arg Asn Met Glu

C20H36N8O8S (548.2377)

Arg Asn Pro Tyr

C24H36N8O7 (548.2707)

Arg Asn Tyr Pro

C24H36N8O7 (548.2707)

Arg Pro Asn Tyr

C24H36N8O7 (548.2707)

Arg Pro Tyr Asn

C24H36N8O7 (548.2707)

Arg Gln Asp Met

C20H36N8O8S (548.2377)

Arg Gln Met Asp

C20H36N8O8S (548.2377)

Arg Arg Cys Asp

C19H36N10O7S (548.2489)

Arg Arg Asp Cys

C19H36N10O7S (548.2489)

Arg Ser Thr Trp

C24H36N8O7 (548.2707)

Arg Ser Trp Thr

C24H36N8O7 (548.2707)

Arg Thr Ser Trp

C24H36N8O7 (548.2707)

Arg Thr Trp Ser

C24H36N8O7 (548.2707)

Arg Trp Gly Met

C24H36N8O5S (548.2529)

Arg Trp Met Gly

C24H36N8O5S (548.2529)

Arg Trp Ser Thr

C24H36N8O7 (548.2707)

Arg Trp Thr Ser

C24H36N8O7 (548.2707)

Arg Tyr Asn Pro

C24H36N8O7 (548.2707)

Arg Tyr Pro Asn

C24H36N8O7 (548.2707)

Ser Ala Trp Trp

C28H32N6O6 (548.2383)

Ser Glu Lys Trp

C25H36N6O8 (548.2594)

Ser Glu Trp Lys

C25H36N6O8 (548.2594)

Ser Lys Glu Trp

C25H36N6O8 (548.2594)

Ser Lys Trp Glu

C25H36N6O8 (548.2594)

Ser Arg Thr Trp

C24H36N8O7 (548.2707)

Ser Arg Trp Thr

C24H36N8O7 (548.2707)

Ser Thr Arg Trp

C24H36N8O7 (548.2707)

Ser Trp Ala Trp

C28H32N6O6 (548.2383)

Ser Trp Glu Lys

C25H36N6O8 (548.2594)

Ser Trp Lys Glu

C25H36N6O8 (548.2594)

Ser Trp Trp Ala

C28H32N6O6 (548.2383)

Thr Asp Lys Trp

C25H36N6O8 (548.2594)

Thr Asp Trp Lys

C25H36N6O8 (548.2594)

Thr Gly Trp Trp

C28H32N6O6 (548.2383)

Thr Lys Asp Trp

C25H36N6O8 (548.2594)

Thr Lys Trp Asp

C25H36N6O8 (548.2594)

Thr Trp Asp Lys

C25H36N6O8 (548.2594)

Thr Trp Gly Trp

C28H32N6O6 (548.2383)

Thr Trp Lys Asp

C25H36N6O8 (548.2594)

Thr Trp Trp Gly

C28H32N6O6 (548.2383)

Val His Met Tyr

C25H36N6O6S (548.2417)

Val His Tyr Met

C25H36N6O6S (548.2417)

Val Met His Tyr

C25H36N6O6S (548.2417)

Val Met Asn Trp

C25H36N6O6S (548.2417)

Val Met Trp Asn

C25H36N6O6S (548.2417)

Val Met Tyr His

C25H36N6O6S (548.2417)

Val Asn Met Trp

C25H36N6O6S (548.2417)

Val Asn Trp Met

C25H36N6O6S (548.2417)

Val Trp Met Asn

C25H36N6O6S (548.2417)

Val Trp Asn Met

C25H36N6O6S (548.2417)

Val Tyr His Met

C25H36N6O6S (548.2417)

Val Tyr Met His

C25H36N6O6S (548.2417)

Trp Ala Ser Trp

C28H32N6O6 (548.2383)

Trp Ala Trp Ser

C28H32N6O6 (548.2383)

Trp Cys Ile Gln

C25H36N6O6S (548.2417)

Trp Cys Leu Gln

C25H36N6O6S (548.2417)

Trp Cys Gln Ile

C25H36N6O6S (548.2417)

Trp Cys Gln Leu

C25H36N6O6S (548.2417)

Trp Asp Lys Thr

C25H36N6O8 (548.2594)

Trp Asp Thr Lys

C25H36N6O8 (548.2594)

Trp Glu Lys Ser

C25H36N6O8 (548.2594)

Trp Glu Ser Lys

C25H36N6O8 (548.2594)

Trp Gly Met Arg

C24H36N8O5S (548.2529)

Trp Gly Arg Met

C24H36N8O5S (548.2529)

Trp Gly Thr Trp

C28H32N6O6 (548.2383)

Trp Gly Trp Thr

C28H32N6O6 (548.2383)

Trp Ile Cys Gln

C25H36N6O6S (548.2417)

Trp Ile Gln Cys

C25H36N6O6S (548.2417)

Trp Lys Asp Thr

C25H36N6O8 (548.2594)

Trp Lys Glu Ser

C25H36N6O8 (548.2594)

Trp Lys Ser Glu

C25H36N6O8 (548.2594)

Trp Lys Thr Asp

C25H36N6O8 (548.2594)

Trp Leu Cys Gln

C25H36N6O6S (548.2417)

Trp Leu Gln Cys

C25H36N6O6S (548.2417)

Trp Met Gly Arg

C24H36N8O5S (548.2529)

Trp Met Asn Val

C25H36N6O6S (548.2417)

Trp Met Arg Gly

C24H36N8O5S (548.2529)

Trp Met Val Asn

C25H36N6O6S (548.2417)

Trp Asn Met Val

C25H36N6O6S (548.2417)

Trp Asn Val Met

C25H36N6O6S (548.2417)

Trp Gln Cys Ile

C25H36N6O6S (548.2417)

Trp Gln Cys Leu

C25H36N6O6S (548.2417)

Trp Gln Ile Cys

C25H36N6O6S (548.2417)

Trp Gln Leu Cys

C25H36N6O6S (548.2417)

Trp Arg Gly Met

C24H36N8O5S (548.2529)

Trp Arg Met Gly

C24H36N8O5S (548.2529)

Trp Ser Ala Trp

C28H32N6O6 (548.2383)

Trp Ser Glu Lys

C25H36N6O8 (548.2594)

Trp Ser Lys Glu

C25H36N6O8 (548.2594)

Trp Ser Trp Ala

C28H32N6O6 (548.2383)

Trp Thr Asp Lys

C25H36N6O8 (548.2594)

Trp Thr Gly Trp

C28H32N6O6 (548.2383)

Trp Thr Lys Asp

C25H36N6O8 (548.2594)

Trp Thr Arg Ser

C24H36N8O7 (548.2707)

Trp Thr Trp Gly

C28H32N6O6 (548.2383)

Trp Val Met Asn

C25H36N6O6S (548.2417)

Trp Val Asn Met

C25H36N6O6S (548.2417)

Trp Trp Ala Ser

C28H32N6O6 (548.2383)

Trp Trp Gly Thr

C28H32N6O6 (548.2383)

Trp Trp Ser Ala

C28H32N6O6 (548.2383)

Trp Trp Thr Gly

C28H32N6O6 (548.2383)

Tyr His Met Val

C25H36N6O6S (548.2417)

Tyr His Val Met

C25H36N6O6S (548.2417)

Tyr Met His Val

C25H36N6O6S (548.2417)

Tyr Met Val His

C25H36N6O6S (548.2417)

Tyr Val His Met

C25H36N6O6S (548.2417)

Tyr Val Met His

C25H36N6O6S (548.2417)

SVQES

C21H36N6O11 (548.2442)

SSVQE

C21H36N6O11 (548.2442)

MLGQT

C22H40N6O8S (548.2628)

15alpha-acetoxy-5alpha-chloro-6beta,14beta,dihydroxy-1-oxo-witha2,24-dien-26,22-olide

C30H41O7Cl (548.2541)

3-[2-(3-hydroxyphenyl)ethyl]-4-[2-[6-(2-phenylethylamino)hexylamino]ethyl]benzene-1,2-diol,dihydrochloride

C30H42Cl2N2O3 (548.2572)

ICG-001

C33H32N4O4 (548.2423)

Murabutide

C23H40N4O11 (548.2693)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007155 - Immunologic Factors

Imazamethabenz

C30H36N4O6 (548.2635)

Herbicidal metabolite of imazamethabenz-methyl. Acetolactate synthase inhibitor

butane-1,4-diol,ethane-1,2-diol,hexanedioic acid,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene

C27H36N2O10 (548.237)

Ajugamarin A 1

C29H40O10 (548.2621)

(6R,9aR)-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide

C33H32N4O4 (548.2423)

[(1R,3S,4R,4aR,5S,7R,8S,8aR)-8-[(3aS,5S,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-4a-(acetyloxymethyl)-3-hydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-1-yl] (E)-2-methylbut-2-enoate

C29H40O10 (548.2621)

Terbutaline sulfate

C24H40N2O10S (548.2404)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

Tamoxifen-N-glucuronide

C32H38NO7+ (548.2648)

Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

(2S,3S,4S,5R)-6-[(3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R)-4-[(1R)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H40O13 (548.2469)

Butyl 2-[2-[2-(2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl)oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoate

C23H40N4O11 (548.2693)

PA(2:0/PGE2)

C25H41O11P (548.2386)

PA(PGE2/2:0)

C25H41O11P (548.2386)

PA(2:0/PGD2)

C25H41O11P (548.2386)

PA(PGD2/2:0)

C25H41O11P (548.2386)

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H41O11P (548.2386)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0)

C25H41O11P (548.2386)

(3S,6S,7R,8aR)-6-[3-(2-hydroxyethoxy)phenyl]-N-[5-[(2-mercapto-1-oxoethyl)amino]pentyl]-3-(2-methylpropyl)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide

C27H40N4O6S (548.2668)

1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea

C28H35F3N4O4 (548.261)

1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea

C28H35F3N4O4 (548.261)

1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea

C28H35F3N4O4 (548.261)

1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea

C28H35F3N4O4 (548.261)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide

C30H36N4O4S (548.2457)

(2R)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C31H36N2O5S (548.2345)

(2S)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C31H36N2O5S (548.2345)

tamoxifen N-beta-D-glucosiduronic acid

C32H38NO7+ (548.2648)

ajugamarin A1

C29H40O10 (548.2621)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

PA 14:1/8:3;O3

C25H41O11P (548.2386)

PA 22:4;O3

C25H41O11P (548.2386)

LPGP O-16:1

C22H46O11P2 (548.2515)

LPGP P-16:0

C22H46O11P2 (548.2515)

ST 19:0;O7;GlcA

C25H40O13 (548.2469)

ST 23:4;O4;GlcA

C29H40O10 (548.2621)

ST 19:1;O8;Hex

C25H40O13 (548.2469)

ST 23:5;O5;Hex

C29H40O10 (548.2621)

ST 26:1;O7;S

C26H44O10S (548.2655)

ST 29:6;O5;S

C29H40O8S (548.2444)

(2r,3'r,4'ar,5's,6'r,6'ar,10'ar,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

7-ethenyl-12-ethyl-21-hydroxy-6,11,27,28-tetramethyl-20-oxa-2,16,29,30-tetraazaheptacyclo[15.8.1.1³,²⁵.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²¹,²⁶]triaconta-1,3,5,7,9,11,13(29),14,17(26),18(28)-decaene-19,22-dione

C33H32N4O4 (548.2423)

(1r,2r,3bs,9br,11ar)-1-acetyl-2,7-dihydroxy-3a,6,9b,11a-tetramethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one

C29H40O10 (548.2621)

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

calotoxin

C29H40O10 (548.2621)

(1'r,2r,2's,4'r,5's,6'r,7's,8's,11'r)-5'-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-2',11'-bis(acetyloxy)-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-7'-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

artanomaloide

C32H36O8 (548.241)

{"Ingredient_id": "HBIN016925","Ingredient_name": "artanomaloide","Alias": "NA","Ingredient_formula": "C32H36O8","Ingredient_Smile": "CC1=C2C(C3C(C(C1)OC(=O)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C","Ingredient_weight": "548.62","OB_score": "NA","CAS_id": "112823-41-3","SymMap_id": "NA","TCMID_id": "1781","TCMSP_id": "NA","TCM_ID_id": "6624","PubChem_id": "102005656","DrugBank_id": "NA"}

8,9,10,22-tetrahydroxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-16-one

C29H40O10 (548.2621)

(1's,2r,3'r,6'r,8'r,13's,14'r,17's,18'e,20'e,24's,25'r)-6',14'-dihydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O10 (548.2621)

1,10-bis(acetyloxy)-6-hydroxy-4a,6a,10b-trimethyl-7-methylidene-5'-oxo-octahydrospiro[naphtho[2,1-b]pyran-3,3'-oxolan]-5-yl 3-methylbut-2-enoate

C29H40O10 (548.2621)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1r,2r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-oxo-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-2-yl (2r)-2-methylbutanoate

C29H40O10 (548.2621)

(2s,3s,4s,5r)-6-{[(3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2r)-4-[(1r)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxy}oxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H40O13 (548.2469)

(4r)-5,5-dimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H40O13 (548.2469)

(1's,2s,2'r,5'r,7's,8's,10'r,12'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-6',9'-dioxaspiro[oxirane-2,13'-tetracyclo[8.2.1.0²,⁸.0⁵,⁷]tridecan]-12'-yl (2z,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O10 (548.2621)

(1r,2s,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-oxo-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-2-yl (2s)-2-methylbutanoate

C29H40O10 (548.2621)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

(1r,2s,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

(3s,7s,9s,10r,12s,14s,18r,19r,22r,23s)-9,10,19,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,17r,18s,19r,22s,23r)-9,10,17,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

2,12-dimethyl 19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

(1r,3r,5s,7r,8r,9r,10s,12r,14s,15r,18r,19r,22s,23r)-8,9,10,22-tetrahydroxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-16-one

C29H40O10 (548.2621)

(2's,3ar,5'r,9's,9as,9br,10's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(1'r,2'r,3r,3ar,4s,5's,9's,9as,9bs,10's,11'r)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H40O13 (548.2469)

1'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

(1r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-oxo-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-2-yl (2s)-2-methylbutanoate

C29H40O10 (548.2621)

methyl (1r,12r,19r)-12-[(1r)-1-(3,4,5-trimethoxybenzoyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C31H36N2O7 (548.2522)

5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-3,4,4a,8-tetrahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylbutanoate

C29H40O10 (548.2621)

9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

7-{3-[(7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene)amino]-1,6-dihydroxy-4-oxocyclohex-2-en-1-yl}-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid

C31H36N2O7 (548.2522)

(3s,5s)-5-(acetyloxy)-1,7-bis(3,4,5-trimethoxyphenyl)heptan-3-yl acetate

C29H40O10 (548.2621)

(1'r,2r,3'r,6's,8'r,12's,13'r,17'r,18'e,20'e,24's,25's)-6',12'-dihydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O10 (548.2621)

(1s,3r,5s,7r,9s,10s,12r,14r,18r,19r,21r,22s)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1's,2'r,3r,3ar,4s,5'r,9's,9ar,9br,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

9,10,22-trihydroxy-7-(hydroxymethyl)-18-methyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,9,10-tris(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C29H40O10 (548.2621)

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,21r,22s,23r)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

18-{3,8-dimethyl-7-oxo-1,6-dioxaspiro[4.4]nonan-2-yl}-1,11-dihydroxy-9,9,18-trimethyl-4,8,15-trioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁹]icosane-5,16-dione

C29H40O10 (548.2621)

5-[1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

(1's,2s,2'r,4's,7'r,9'r,11'r)-4'-hydroxy-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O10 (548.2621)

5a-chloro-1-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-3a,5-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C30H41ClO7 (548.2541)

methyl 2-[(1ar,1bs,2r,6as)-6-[(2r)-2-[(1ar,1bs,2r,6as)-2-hydroxy-1b,6-dimethyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]-3-methoxy-2-methyl-3-oxopropyl]-2-hydroxy-1b-methyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]prop-2-enoate

C32H36O8 (548.241)

methyl 12-[1-(3,4,5-trimethoxybenzoyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C31H36N2O7 (548.2522)

(2e,4e,6e)-7-[(1s,6r)-3-{[(2e,4e,6e)-7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene]amino}-1,6-dihydroxy-4-oxocyclohex-2-en-1-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid

C31H36N2O7 (548.2522)

(1r,3s,3as,3br,5r,5ar,9as,9bs,11ar)-5a-chloro-1-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-3a,5-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C30H41ClO7 (548.2541)

2,15-dihydroxy-17-[1-hydroxy-1-(4-methyl-5-oxooxolan-2-yl)propan-2-yl]-9,9,18-trimethyl-4,8,21-trioxahexacyclo[13.5.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,¹⁸]henicosane-5,14-dione

C29H40O10 (548.2621)

(9r,10s)-10-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl (2e)-3-phenylprop-2-enoate

C32H36O8 (548.241)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

(1s,2s,4r,5r,10s,11s,13s,15s,16r,17r,20s)-5-chloro-15-[(2r)-3,4-dimethyl-5-oxo-2h-furan-2-yl]-13-ethoxy-4,17-dihydroxy-10,16,20-trimethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁷,²⁰]icos-7-en-9-one

C30H41ClO7 (548.2541)

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e)-1-hydroxy-2,10,12-trimethyl-13-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]trideca-2,4,6,8,10,12-hexaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C30H36N4O6 (548.2635)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,9,10-tris(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C29H40O10 (548.2621)

5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

(1's,2's,3s,3ar,4s,6's,9'r,9as,9br,10's,13'r)-9'-hydroxy-6,9,9',13'-tetramethyl-5'-methylidene-2,4',7-trioxo-4,5,9a,9b-tetrahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[8.3.2.0¹,¹⁰.0²,⁶]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

2,12-dimethyl (2s,5r,7s,8r,12s,15r,17s,18r,19s,24s)-19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

n-[7,10-dimethyl-12-(2-methylpropyl)-2,5,9,11-tetraoxo-3-(sec-butyl)-1,4,8-trioxacyclododecan-6-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C27H36N2O10 (548.237)

9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

methyl 2-[2-hydroxy-6-(2-{2-hydroxy-1b,6-dimethyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl}-3-methoxy-2-methyl-3-oxopropyl)-1b-methyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]prop-2-enoate

C32H36O8 (548.241)

(1s,3r,4ar,5s,6r,6ar,10r,10as,10bs)-1,10-bis(acetyloxy)-6-hydroxy-4a,6a,10b-trimethyl-7-methylidene-5'-oxo-octahydrospiro[naphtho[2,1-b]pyran-3,3'-oxolan]-5-yl 3-methylbut-2-enoate

C29H40O10 (548.2621)

(1r,2s,3r,4s,5s,6r,7r,8r,9r,12r,13s)-5,9-bis(acetyloxy)-3-(chloromethyl)-3,12,13-trihydroxy-6-isopropyl-9,13-dimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl acetate

C26H41ClO10 (548.2388)

14-(1-hydroxyethyl)-4,11,17-triisopropyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H36N6O6S (548.2417)

2,12-dimethyl (2s,5r,7s,8r,12s,15r,17s,18s,19s,24s)-19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

(4s,11s,14s,17s)-14-[(1r)-1-hydroxyethyl]-4,11,17-triisopropyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H36N6O6S (548.2417)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,18r,19r,21r,22s,23r)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1's,2'r,3r,3ar,4s,5's,9's,9as,9br,10's,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

[(1r,3as,3br,5as,7s,8s,9as,9bs,11ar)-1-[(2r)-hept-6-en-2-yl]-9a,11a-dimethyl-8-(sulfooxy)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid

C26H44O8S2 (548.2477)

9'-hydroxy-6,9,9',13'-tetramethyl-5'-methylidene-2,4',7-trioxo-4,5,9a,9b-tetrahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[8.3.2.0¹,¹⁰.0²,⁶]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

5-chloro-15-(3,4-dimethyl-5-oxo-2h-furan-2-yl)-13-ethoxy-4,17-dihydroxy-10,16,20-trimethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁷,²⁰]icos-7-en-9-one

C30H41ClO7 (548.2541)

(1s,3r,5s,6r,8r,10s,12r,14r,15s,18r,19r,21r,22s,23r)-5,6,21,22-tetrahydroxy-8,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,3r,7r,10s,11s,13r,14s,18r,19r)-18-[(2r,3r,5r,8s)-3,8-dimethyl-7-oxo-1,6-dioxaspiro[4.4]nonan-2-yl]-1,11-dihydroxy-9,9,18-trimethyl-4,8,15-trioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁹]icosane-5,16-dione

C29H40O10 (548.2621)

(1s,3r,5s,7r,8s,9r,10s,12r,14r,15s,18r,19r,22s,23r)-8,9,10,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1r,2s,3s,7r,10s,13r,15s,16s,17r,18r)-2,15-dihydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-9,9,18-trimethyl-4,8,21-trioxahexacyclo[13.5.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,¹⁸]henicosane-5,14-dione

C29H40O10 (548.2621)

(1r,2s,4r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

methyl (1s,12s,19s)-12-[(1r)-1-(3,4,5-trimethoxybenzoyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C31H36N2O7 (548.2522)

(1s,3r,5s,7s,9r,10s,12r,14r,15s,18r,19r,22s,23r)-9,10,22-trihydroxy-7-(hydroxymethyl)-18-methyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1's,2r,3's,4'as,6's,6'ar,10'ar,10'bs)-1'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

(2's,3ar,4s,5's,9's,9as,9br,10's,11'r)-4-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-2'-yl acetate

C32H36O8 (548.241)

10-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl 3-phenylprop-2-enoate

C32H36O8 (548.241)

(1'r,2s,3'r,6'r,8'r,13's,14'r,17'r,18'e,20'z,24'r,25's)-6',14'-dihydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O10 (548.2621)

(3s,6s,9s,12s)-3-benzyl-6,12-bis(furan-3-ylmethyl)-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C30H36N4O6 (548.2635)

3-hydroxy-2-[(1-hydroxy-2,10,12-trimethyl-13-{5-methyl-2-[2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl}trideca-2,4,6,8,10,12-hexaen-1-ylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

C30H36N4O6 (548.2635)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-oxo-5-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-2-yl 2-methylbutanoate

C29H40O10 (548.2621)

(2r,3'r,4'ar,5'r,6'r,6'ar,10'as,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

6-{[(1s,2s,3r,4ar,4bs,7s,10ar)-7-(2-chloro-1-hydroxyethyl)-2,3-dihydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H41ClO10 (548.2388)

(2's,3s,3ar,5'r,9's,9as,9br,10's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

6-{[7-(2-chloro-1-hydroxyethyl)-2,3-dihydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H41ClO10 (548.2388)

9,10,17,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

2',11'-bis(acetyloxy)-5'-{hexahydrofuro[2,3-b]furan-2-yl}-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-7'-yl 2-methylbut-2-enoate

C29H40O10 (548.2621)

(1r,4ar,5s,6s,8s,8ar)-5-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

1,9,10-tris(acetyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C29H40O10 (548.2621)

methyl 2-{3-[1-(acetyloxy)ethyl]-6-[(2-methylbutanoyl)oxy]-7-methylidene-5-[(3-methylpent-2-enoyl)oxy]-2-oxo-hexahydro-1h-inden-4-yl}oxirane-2-carboxylate

C29H40O10 (548.2621)

(1r,4r,4ar,5s)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C29H40O10 (548.2621)

4-[2-(benzyloxy)-4-methoxy-6-(2-oxononyl)benzoyloxy]-2-hydroxy-6-methylbenzoic acid

C32H36O8 (548.241)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-[(2s)-2-hydroxy-2-(5-oxo-2h-furan-3-yl)ethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2z)-2-methylbut-2-enoate

C29H40O10 (548.2621)

3-benzyl-6,12-bis(furan-3-ylmethyl)-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C30H36N4O6 (548.2635)